Twist Bioscience prices upsized $300 million stock offering, closes August 6
The company sold 3,125,000 shares at $96.00 apiece and expects roughly $327.1 million in net proceeds after underwriters' full option exercise.
SEC filing (3)
Latest
2 stories
Wednesday, August 5
Monday, August 3
Twist Bioscience posts record quarterly revenue, raises full-year guidance
The company reported $118.4 million in fiscal third-quarter revenue and raised its fiscal 2026 revenue outlook to $456-$457 million.
SEC filing